NO20054140L - Dihydrospiro-[cykloalkyl]-pyrimidonderivat, anvendelser derav for fremstilling av et medikament, medikament omfattende en slik forbindelse, og mellomproduktforbindelse - Google Patents

Dihydrospiro-[cykloalkyl]-pyrimidonderivat, anvendelser derav for fremstilling av et medikament, medikament omfattende en slik forbindelse, og mellomproduktforbindelse

Info

Publication number: NO20054140L
Authority: NO; Norway
Prior art keywords: medicament; ring; compound; optionally substituted; dihydrospiro
Prior art date: 2003-03-07

Application number

NO20054140A

Other languages

English (en)

Norwegian (no)

Other versions

NO20054140D0 (no

Inventor

Alistair William Lochead

Pascal George

Mourad Saady

Franck Slowinski

Philippe Yaiche

Original Assignee

Mitsubishi Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-07

Filing date

2005-09-06

Publication date

2005-12-02

2005-09-06 Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp

2005-09-06 Publication of NO20054140D0 publication Critical patent/NO20054140D0/no

2005-12-02 Publication of NO20054140L publication Critical patent/NO20054140L/no

Links

239000003814 drug Substances 0.000 title abstract 3
125000000753 cycloalkyl group Chemical group 0.000 title abstract 2
150000008318 pyrimidones Chemical class 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 title 2
238000004519 manufacturing process Methods 0.000 title 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
208000024827 Alzheimer disease Diseases 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
239000000470 constituent Substances 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
230000003449 preventive effect Effects 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
125000004434 sulfur atom Chemical group 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Psychiatry (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Psychology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20054140A 2003-03-07 2005-09-06 Dihydrospiro-[cykloalkyl]-pyrimidonderivat, anvendelser derav for fremstilling av et medikament, medikament omfattende en slik forbindelse, og mellomproduktforbindelse NO20054140L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03290569A EP1454909B1 (de)	2003-03-07	2003-03-07	8'-pyridinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a) pyrimidin-6-one und 8'-pyrimidinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a)pyrimidin-6-one Derivate und deren Benutzung gegen neurodegenerative Krankheiten
PCT/EP2004/003051 WO2004078760A1 (en)	2003-03-07	2004-03-05	SUBSTITUTED 8'-PYRIDINYL-DIHYDROSPIRO-[CYCLOALKYL]-PYRIMIDO [1,2-a] PYRIMIDIN-6-ONE AND 8'-PYRIMIDINYL-DIHYDROSPIRO-[CYCLOALKYL]-PYRIMIDO [1,2-a] PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES

Publications (2)

Publication Number	Publication Date
NO20054140D0 NO20054140D0 (no)	2005-09-06
NO20054140L true NO20054140L (no)	2005-12-02

Family

ID=32799103

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054140A NO20054140L (no)	2003-03-07	2005-09-06	Dihydrospiro-[cykloalkyl]-pyrimidonderivat, anvendelser derav for fremstilling av et medikament, medikament omfattende en slik forbindelse, og mellomproduktforbindelse

Country Status (25)

Country	Link
US (2)	US7294632B2 (de)
EP (2)	EP1454909B1 (de)
JP (1)	JP4639182B2 (de)
KR (1)	KR101069984B1 (de)
CN (1)	CN100463908C (de)
AR (1)	AR043485A1 (de)
AT (1)	ATE469153T1 (de)
AU (1)	AU2004218250B2 (de)
BR (1)	BRPI0408189A (de)
CA (1)	CA2516937C (de)
CY (1)	CY1111057T1 (de)
DE (1)	DE602004027354D1 (de)
DK (1)	DK1603915T3 (de)
EA (1)	EA008172B1 (de)
ES (1)	ES2346311T3 (de)
IL (1)	IL170461A (de)
MX (1)	MXPA05009574A (de)
NO (1)	NO20054140L (de)
NZ (1)	NZ542135A (de)
PL (1)	PL1603915T3 (de)
PT (1)	PT1603915E (de)
SI (1)	SI1603915T1 (de)
TW (1)	TWI320785B (de)
WO (1)	WO2004078760A1 (de)
ZA (1)	ZA200507107B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20080025079A (ko)	2005-06-14	2008-03-19	쉐링 코포레이션	아스파르틸 프로테아제 억제제
EP2275095A3 (de)	2005-08-26	2011-08-17	Braincells, Inc.	Neurogenese durch modulation des Muscarinrezeptors
EP2258358A3 (de)	2005-08-26	2011-09-07	Braincells, Inc.	Neurogenese mit Acetylcholinesterasehemmer
EP1940389A2 (de)	2005-10-21	2008-07-09	Braincells, Inc.	Modulation von neurogenese durch pde-hemmung
AU2006308889A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
EP2382975A3 (de)	2006-05-09	2012-02-29	Braincells, Inc.	Neurogenese mittels Angiotensin-Modulation
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
EP1992624A1 (de)	2007-05-16	2008-11-19	Sanofi-Aventis	Heteroarylamid-Pyrimidon-Verbindungen
EP1992625A1 (de) *	2007-05-16	2008-11-19	Sanofi-Aventis	Arylamid-Pyrimidon-Verbindungen
EP1992621A1 (de)	2007-05-16	2008-11-19	Sanofi-Aventis	Heteroarylamid-substituierte Pyrimidon-Derivate zur Behandlung von neurodegenerativen Krankheiten
EP1992620A1 (de) *	2007-05-16	2008-11-19	Sanofi-Aventis	Arylamid-Pyrimidon-Derivate zur Behandlung von neurodegenerativen Krankheiten
EP2138498A1 (de)	2008-06-26	2009-12-30	sanofi-aventis	Substituierte trizyklische Derivate gegen neurodegenerative Erkrankungen
EP2138488A1 (de)	2008-06-26	2009-12-30	sanofi-aventis	4-(Pyridin-4-yl)-1H-[1,3,5]Triazin-2-one-Verbindungen als GSK3-beta Hemmer zur Behandlung neurodegenerative Erkrankungen
EP2138485A1 (de)	2008-06-26	2009-12-30	sanofi-aventis	Substituierte N-Oxid-Pyrazin-Derivate
EP2138495A1 (de) *	2008-06-26	2009-12-30	sanofi-aventis	Substituierte Pyrimido[2,1-a]isochinolin-4-on-Derivate
EP2138494A1 (de)	2008-06-26	2009-12-30	Sanofi-Aventis	Substituierte Alkylpyrimidin-4-one-Derivate
EP2138492A1 (de)	2008-06-26	2009-12-30	Sanofi-Aventis	Substituierte Pyrimidin-4-one-Derivate
EP2138493A1 (de)	2008-06-26	2009-12-30	Sanofi-Aventis	Substituierte Pyrimidon-Derivate
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
CN102482286B (zh)	2009-07-02	2015-07-15	赛诺菲	新型1,2,3,4-四氢嘧啶并{1,2-a}嘧啶-6-酮衍生物、其制备以及其医药用途
DK2655375T3 (en)	2010-12-23	2015-03-09	Sanofi Sa	PYRIMIDINON DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF
FR2992316A1 (fr)	2012-06-22	2013-12-27	Sanofi Sa	Derives de pyrimidinones, leur preparation et leur application en therapeutique
FR2992314B1 (fr)	2012-06-22	2015-10-16	Sanofi Sa	Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
CA2945263A1 (en)	2014-04-09	2015-10-15	Christopher Rudd	Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2812636A1 (fr) *	2000-08-02	2002-02-08	Novapharme	Nouveaux derives 2-phenyl imidazo[1.2-a]pyrimidin-5-ones et 2-phenyl 2,3-dihydro imidazo[1,2-a]pyrimidin-5-ones
EP1184383A1 (de) *	2000-09-01	2002-03-06	Sanofi-Synthelabo	9-[Alkyl], 9-[(Heteroaryl)alkyl] und 9-[(Aryl)alkyl]-2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on Derivate
EP1184385A1 (de) *	2000-09-01	2002-03-06	Sanofi-Synthelabo	1-[Alkyl], 1-[(Heteroaryl)alkyl] und 1[(Aryl)alkyl]-7-pyridin-4-yl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)-on Derivate
AR030587A1 (es) *	2000-09-01	2003-08-27	Sanofi Aventis	Derivados de 2-piridinil-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona y 7-piridinil-2,3-dihidroimidazo[1,2-a]pirimidin-5(1h)-ona
CA2457965C (en) *	2001-09-21	2010-06-01	Sanofi-Synthelabo	Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
EA007165B1 (ru) *	2001-09-21	2006-08-25	Санофи-Авентис	Производные замещенного 2-пиримидинил-6, 7, 8, 9-тетрагидропиримидо [1,2-а]пиримидин-4-она и 7-пиримидинил-2,3-дигидроимидазо[1, 2-а]пиримидин-5( 1н )она для нейродегенеративных нарушений
EP1295884A1 (de) *	2001-09-21	2003-03-26	Sanofi-Synthelabo	2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)on Derivate
EP1295885A1 (de) *	2001-09-21	2003-03-26	Sanofi-Synthelabo	Substituierte 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)onderivate

2003
- 2003-03-07 EP EP03290569A patent/EP1454909B1/de not_active Expired - Lifetime
2004
- 2004-03-05 AT AT04717643T patent/ATE469153T1/de active
- 2004-03-05 DK DK04717643.3T patent/DK1603915T3/da active
- 2004-03-05 ZA ZA200507107A patent/ZA200507107B/en unknown
- 2004-03-05 CA CA2516937A patent/CA2516937C/en not_active Expired - Fee Related
- 2004-03-05 EA EA200501241A patent/EA008172B1/ru not_active IP Right Cessation
- 2004-03-05 ES ES04717643T patent/ES2346311T3/es not_active Expired - Lifetime
- 2004-03-05 PL PL04717643T patent/PL1603915T3/pl unknown
- 2004-03-05 NZ NZ542135A patent/NZ542135A/en not_active IP Right Cessation
- 2004-03-05 DE DE602004027354T patent/DE602004027354D1/de not_active Expired - Lifetime
- 2004-03-05 MX MXPA05009574A patent/MXPA05009574A/es active IP Right Grant
- 2004-03-05 SI SI200431465T patent/SI1603915T1/sl unknown
- 2004-03-05 JP JP2006504813A patent/JP4639182B2/ja not_active Expired - Fee Related
- 2004-03-05 BR BRPI0408189-7A patent/BRPI0408189A/pt not_active IP Right Cessation
- 2004-03-05 EP EP04717643A patent/EP1603915B1/de not_active Expired - Lifetime
- 2004-03-05 CN CNB2004800109973A patent/CN100463908C/zh not_active Expired - Fee Related
- 2004-03-05 AR ARP040100694A patent/AR043485A1/es not_active Application Discontinuation
- 2004-03-05 PT PT04717643T patent/PT1603915E/pt unknown
- 2004-03-05 TW TW093105914A patent/TWI320785B/zh not_active IP Right Cessation
- 2004-03-05 AU AU2004218250A patent/AU2004218250B2/en not_active Ceased
- 2004-03-05 WO PCT/EP2004/003051 patent/WO2004078760A1/en not_active Ceased
2005
- 2005-08-23 IL IL170461A patent/IL170461A/en not_active IP Right Cessation
- 2005-09-06 KR KR1020057016622A patent/KR101069984B1/ko not_active Expired - Fee Related
- 2005-09-06 NO NO20054140A patent/NO20054140L/no not_active Application Discontinuation
- 2005-09-07 US US11/220,999 patent/US7294632B2/en not_active Expired - Fee Related
2007
- 2007-10-02 US US11/866,142 patent/US7507743B2/en not_active Expired - Fee Related
2010
- 2010-08-17 CY CY20101100761T patent/CY1111057T1/el unknown

Also Published As

Publication number	Publication date
AR043485A1 (es)	2005-08-03
TW200510418A (en)	2005-03-16
CY1111057T1 (el)	2015-06-11
KR20050106500A (ko)	2005-11-09
CN100463908C (zh)	2009-02-25
JP2006519814A (ja)	2006-08-31
EP1603915B1 (de)	2010-05-26
IL170461A (en)	2011-11-30
EA008172B1 (ru)	2007-04-27
EP1603915A1 (de)	2005-12-14
HK1085740A1 (en)	2006-09-01
US20080081819A1 (en)	2008-04-03
DK1603915T3 (da)	2010-08-30
WO2004078760A1 (en)	2004-09-16
PT1603915E (pt)	2010-07-22
BRPI0408189A (pt)	2006-03-21
ES2346311T3 (es)	2010-10-14
EA200501241A1 (ru)	2006-04-28
EP1454909A1 (de)	2004-09-08
NZ542135A (en)	2008-06-30
US7507743B2 (en)	2009-03-24
DE602004027354D1 (de)	2010-07-08
JP4639182B2 (ja)	2011-02-23
TWI320785B (en)	2010-02-21
ATE469153T1 (de)	2010-06-15
NO20054140D0 (no)	2005-09-06
CN1777607A (zh)	2006-05-24
KR101069984B1 (ko)	2011-10-04
SI1603915T1 (sl)	2010-08-31
US20060025431A1 (en)	2006-02-02
AU2004218250A1 (en)	2004-09-16
ZA200507107B (en)	2006-11-29
PL1603915T3 (pl)	2010-10-29
US7294632B2 (en)	2007-11-13
EP1454909B1 (de)	2008-08-20
CA2516937A1 (en)	2004-09-16
CA2516937C (en)	2011-10-25
MXPA05009574A (es)	2006-05-19
AU2004218250B2 (en)	2010-02-25

Legal Events

Date	Code	Title	Description
2012-09-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20054140L (no)	2005-12-02	Dihydrospiro-[cykloalkyl]-pyrimidonderivat, anvendelser derav for fremstilling av et medikament, medikament omfattende en slik forbindelse, og mellomproduktforbindelse
NO20054330L (no)	2005-12-21	8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
NO20054331L (no)	2005-12-21	Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
NO20063187L (no)	2006-09-19	Substituerte 8'-pyri(mi)dinyl-dihydrospiro-[cykloalkylamin]-pyrimido[1,2-a]pyrimidin-6-on-derivater
NO20064456L (no)	2006-10-02	Thiadiazolidinoner som GSK-3 inhibitorer
MX2009004884A (es)	2009-05-21	Derivados 8-piperidinil-2-piridinil-pirimido [1,2-a] pirimidin-6-ona y 8-piperidinil-2-pirimidinil-pirimido [1,2-a] pirimidin-6-ona sustuidos.
NO20092373L (no)	2009-08-28	Substituerte heteroarylpyridopyrimidonderivater
MX2009006947A (es)	2009-07-10	Derivados de pirimidona 6-heterociclica 2-sustituida.
WO2007057790A3 (en)	2007-10-11	Substituted bicyclic pyrimidone derivatives
NO20064726L (no)	2006-12-22	Imidazolforbindelser for behandling av neurodegenerative forstyrrelser
NO20090749L (no)	2009-03-06	Arylaminoaryl-alkyl-substituerte imidazolidin-2,4-dioner, fremgangsmate for fremstilling derav, medikamenter inneholdende forbindelsene og deres anvendelse
SG161217A1 (en)	2010-05-27	New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
BRPI0515851A (pt)	2008-08-12	composto de pirimidona
DE60335404D1 (de)	2011-01-27	Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges
MX2010002765A (es)	2010-05-19	Derivado de 6-pirimidinil-pirimid-4-ona.
DE502005003310D1 (de)	2008-04-30	Cycloalkyl substituierte 7-amino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ZA202405279B (en)	2025-10-29	Heteroaryl derivative and use thereof
NO20054141L (no)	2005-12-07	2-(diazabicykloalkyl)pyrimidonderivat, anvendelser derav for fremstilling av et medikament, medikament omfattende en slik forbindelse og mellomproduktforbindelse
ATE480535T1 (de)	2010-09-15	Neue pyridoncarboxylsäurederivative oder salze daraus
TH106080A (th)	2011-02-24	อนุพันธ์ของ 2-ที่ถูกแทนที่-6-เฮเทอโรไซคลิค ไพริมิโดน
TH82134B (th)	2007-01-04	อนุพันธ์ซับสทิทิวเทค 2-(ไอแอซา-ไบไซโคล-แอลคิล)-ไพริมิโดน
NO20063875L (no)	2006-09-26	Forbindelser som anvendes for behandling av sykdommer